Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Knockdown of TRIM32 inhibits tumor growth and increases the therapeutic sensitivity to temozolomide in glioma in a p53-dependent and -independent manner
Yu Cai, Wei Gu, Kang Cheng, et al.
Biochemical and Biophysical Research Communications (2021) Vol. 550, pp. 134-141
Closed Access | Times Cited: 12

Showing 12 citing articles:

Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape
Junjie Gu, Jingyi Chen, Shuaixi Xiang, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 147-179
Open Access | Times Cited: 12
CDK2-activated TRIM32 phosphorylation and nuclear translocation promotes radioresistance in triple-negative breast cancer
Jianming Tang, Jing Li, Jiayan Lian, et al.
Journal of Advanced Research (2023) Vol. 61, pp. 239-251
Open Access | Times Cited: 11
Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities
A. Awan, Maryiam Jama Ali Osman, Omar M. Khan
Cells (2025) Vol. 14, Iss. 2, pp. 69-69
Open Access
miR-29a sensitizes the response of glioma cells to temozolomide by modulating the P53/MDM2 feedback loop
Qiudan Chen, Weifeng Wang, Shuying Chen, et al.
Cellular & Molecular Biology Letters (2021) Vol. 26, Iss. 1
Open Access | Times Cited: 15
TRIM8: a double-edged sword in glioblastoma with the power to heal or hurt
Hamed Hosseinalizadeh, Omid Mohamadzadeh, Mohammad Saeed Kahrizi, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 6
Systematic Review of Molecular Targeted Therapies for Adult-Type Diffuse Glioma: An Analysis of Clinical and Laboratory Studies
Logan Muzyka, Nicolas K. Goff, Nikita Choudhary, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10456-10456
Open Access | Times Cited: 6
Fibronectin Type III Domain Containing 3B as a Potential Prognostic and Therapeutic Biomarker for Glioblastoma
Hyuk-Jun Kwon, Minji Yun, Taek Hyun Kwon, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3168-3168
Open Access | Times Cited: 5
Expression analysis of human glioma susceptibility gene and P53 in human glioma and its clinical significance based on bioinformatics
Baiyu Li, Hang Li, Linghui Zhang, et al.
Annals of Translational Medicine (2023) Vol. 11, Iss. 2, pp. 53-53
Open Access | Times Cited: 4
Fibronectin Type III Domain Containing 3B as a Potential Prognostic and Therapeutic Biomarker for Glioblastoma
Hyuk-Jun Kwon, Minji Yun, Minji Bang, et al.
(2023)
Open Access | Times Cited: 4
Emerging Roles of TRIM Family Proteins in Gliomas Pathogenesis
Angeliki-Ioanna Giannopoulou, Charalampos Xanthopoulos, Christina Piperi, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4536-4536
Open Access | Times Cited: 6
Inhibition of TRIM32 by ibr‐7 treatment sensitizes pancreatic cancer cells to gemcitabine via mTOR/p70S6K pathway
Bo Zhang, Youyou Yan, Yang‐qin Gu, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 26, Iss. 2, pp. 515-526
Open Access | Times Cited: 7
The roles of ubiquitination‐mediated intrinsic apoptotic signalling in cancer therapy
Tiantian Che, Zhenghong Lin
Clinical and Translational Discovery (2022) Vol. 2, Iss. 2
Open Access | Times Cited: 2
Page 1

Scroll to top